Revenue,
USD USD 81.47 Bn
Forecast Year,
USD USD 123.45 Bn
CAGR, 2025 -
4.45%
Report Coverage
Worldwide
In Vitro Diagnostics Market Size Analysis
In Vitro Diagnostics Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Instruments | 24.42 | 25.53 | 26.63 | 27.78 | 29.02 | 30.30 | 31.64 | 33.06 | 34.53 | 36.06 | 37.71 |
| Reagents | 44.82 | 46.81 | 48.94 | 51.16 | 53.43 | 55.82 | 58.33 | 60.92 | 63.63 | 66.49 | 69.40 |
| Services | 12.23 | 12.76 | 13.32 | 13.90 | 14.51 | 15.16 | 15.82 | 16.52 | 17.25 | 18.00 | 18.81 |
In Vitro Diagnostics Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunoassay | 20.38 | 21.28 | 22.22 | 23.19 | 24.23 | 25.30 | 26.41 | 27.60 | 28.82 | 30.07 | 31.38 |
| Hematology | 12.22 | 12.77 | 13.35 | 13.93 | 14.55 | 15.20 | 15.86 | 16.55 | 17.29 | 18.08 | 18.88 |
| Clinical Chemistry | 16.28 | 16.98 | 17.72 | 18.50 | 19.33 | 20.17 | 21.09 | 22.05 | 23.04 | 24.05 | 25.14 |
| Molecular Diagnostics | 14.66 | 15.33 | 16.03 | 16.77 | 17.52 | 18.33 | 19.13 | 19.97 | 20.85 | 21.79 | 22.78 |
| Coagulation | 5.71 | 5.97 | 6.24 | 6.53 | 6.81 | 7.12 | 7.43 | 7.75 | 8.11 | 8.48 | 8.86 |
| Microbiology | 8.14 | 8.49 | 8.87 | 9.26 | 9.66 | 10.08 | 10.55 | 11.01 | 11.49 | 12.01 | 12.53 |
| Others | 4.08 | 4.27 | 4.46 | 4.66 | 4.87 | 5.08 | 5.32 | 5.56 | 5.81 | 6.07 | 6.35 |
In Vitro Diagnostics Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Infectious Diseases | 24.44 | 25.54 | 26.66 | 27.84 | 29.08 | 30.35 | 31.71 | 33.12 | 34.64 | 36.17 | 37.74 |
| Diabetes | 12.22 | 12.78 | 13.36 | 13.96 | 14.57 | 15.24 | 15.90 | 16.59 | 17.32 | 18.09 | 18.89 |
| Oncology | 16.28 | 16.99 | 17.75 | 18.54 | 19.37 | 20.23 | 21.15 | 22.07 | 23.03 | 24.06 | 25.14 |
| Cardiology | 8.14 | 8.50 | 8.88 | 9.26 | 9.69 | 10.11 | 10.56 | 11.05 | 11.54 | 12.06 | 12.61 |
| Nephrology | 4.08 | 4.27 | 4.46 | 4.65 | 4.86 | 5.07 | 5.29 | 5.53 | 5.78 | 6.04 | 6.30 |
| Autoimmune Diseases | 6.52 | 6.81 | 7.11 | 7.44 | 7.76 | 8.10 | 8.46 | 8.85 | 9.24 | 9.65 | 10.08 |
| Drug Testing | 5.70 | 5.95 | 6.21 | 6.49 | 6.78 | 7.09 | 7.40 | 7.73 | 8.07 | 8.42 | 8.81 |
| Others | 4.07 | 4.26 | 4.45 | 4.66 | 4.87 | 5.08 | 5.31 | 5.56 | 5.80 | 6.06 | 6.34 |
In Vitro Diagnostics Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 32.58 | 34.04 | 35.55 | 37.13 | 38.81 | 40.55 | 42.38 | 44.27 | 46.23 | 48.27 | 50.43 |
| Home-care | 12.23 | 12.76 | 13.34 | 13.93 | 14.57 | 15.21 | 15.91 | 16.61 | 17.37 | 18.13 | 18.94 |
| Laboratory | 28.51 | 29.77 | 31.10 | 32.49 | 33.90 | 35.40 | 36.93 | 38.57 | 40.29 | 42.10 | 43.95 |
| Others | 8.15 | 8.52 | 8.89 | 9.28 | 9.69 | 10.13 | 10.57 | 11.05 | 11.52 | 12.05 | 12.59 |
In Vitro Diagnostics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 28.55 | 29.81 | 31.14 | 32.50 | 33.95 | 35.46 | 37.03 | 38.67 | 40.39 | 42.17 | 44.07 |
| Asia Pacific | 22.78 | 23.81 | 24.88 | 25.98 | 27.12 | 28.33 | 29.58 | 30.90 | 32.27 | 33.73 | 35.25 |
| Europe | 20.36 | 21.27 | 22.21 | 23.23 | 24.26 | 25.34 | 26.48 | 27.66 | 28.90 | 30.18 | 31.49 |
| Latin America | 5.71 | 5.96 | 6.21 | 6.50 | 6.79 | 7.10 | 7.42 | 7.75 | 8.09 | 8.46 | 8.84 |
| Middle East and Africa | 4.07 | 4.26 | 4.44 | 4.64 | 4.85 | 5.06 | 5.28 | 5.52 | 5.76 | 6.01 | 6.27 |
In Vitro Diagnostics Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com